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ORIGINAL ARTICLE
The incidence of regional lymph node metastasis
in oral carcinoma varies from 6% to 85%.1 For
the oral cancer patient with regional lymph node
metastasis, the survival rate is decreased to 50%.2
Since the presence of neck lymph node meta-
stasis is the most significant prognostic factors
for oral squamous cell carcinoma (OSCC),3 and
yno current imaging technique can unequivocall
identify the presence of cervical metastatic lymph
nodes, elective neck dissection is one of the stan-
dard treatment strategies. Due to the lack of oc-
cult metastasis in the five neck levels, there is no
indication for comprehensive elective neck dis-
section in pathologic N0 cases.4 fThe concept o
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selective neck dissection (SND), which removes
a selected group of lymph nodes with high risk
occult metastasis, was introduced in the 1980s. 
A study of 501 patients undergoing 516 radical
neck dissections by Shah in 1990 found that level
I–III lymph nodes had the greatest risk of nodal
metastasis from primary OSCC.5 Therefore,
SOHND became the most widely used modality
of SND.6–10 SOHND has a neck recurrence and
survival rate similar to that of modified radical
neck dissection (MRND). As MRND has a higher
postoperative morbidity rate,1,8,11 SOHND is the
most widely used treatment modality for OSCC
patients with N0 and selected N1 status.8,12,13 In
this study, we evaluated the clinical outcome of
OSCC patients treated with SOHND.
Methods
This retrospective study reviewed 328 surgically
treated OSCC patients with clinical N0, N1 and
selected N2a in levels I–III treated at the oral
and maxillofacial surgery department of Chi-Mei
Medical Center in Taiwan between 1992 and 1999.
The N stage was diagnosed based on physical
examination and computed tomography or mag-
netic resonance imaging findings. Patients were
excluded if they met any of the following criteria:
recurrence or a second primary tumor; occur-
rence in association with a synchronous primary
tumor outside the oral cavity; past history of head
and neck cancer; previous radiation therapy to the
head and neck. Patients with insufficient patho-
logic findings or with insufficient clinical follow-
up data were also excluded.
According to the methods of Hyam et al,14
patients were divided into the following three age
groups: younger than 40 years; 40–60 years; older
than 60 years. TNM status and clinical stages of
oral cancer were determined according to the AJCC
TNM staging system (5th edition). The general pro-
tocol was to administer postoperative radiotherapy
to patients undergoing elective neck dissection
who had one or more lymph node metastases,
extracapsular spread, perineural invasion, close
rsurgical margin, and advanced primary tumo
(T3 and T4). The neck radiation field included
the lower neck and employed a radiation oncol-
ogy protocol. However, the treatment procedure
was decided on an individual basis and always
after consultation with a radiation oncologist.
Neck disease-free survival was defined as the
interval between the date of the SOHND and the
date of the last consultation or neck recurrence.
Survival distributions were analyzed using Kaplan-
gMeier curves. The N status was compared usin
χ2 and log rank tests. A p value less than 0.05 was
considered statistically significant.
Results
A total of 257 OSCC patients (247 men, 10
women; mean age, 47 years; age range, 25–75
years) who simultaneously received wide excision
and SOHND were included. According to the
methods of Hyam et al, these patients were divided
into three age groups as follows: 45 (18%) patients
aged younger than 40 years, 164 (63%) patients
raged 40–60 years, and 48 (19%) patients olde
than 60 years. The OSCC sites in these patients
included 119 (46%) buccal mucosa, 63 (25%)
tongue, 33 (13%) lower gingiva, and 42 (16%)
other (Table 1).
According to the AJCC TNM staging system,
64 (24.9%) cases were classified as T1, 97 (37.7%)
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Table 1. Distribution of sex, age and cancer site in
257 patients with oral squamous cell
carcinoma
Variable Category Patients, n (%)
Sex Men 247 (96)
Women 10 (4)
Age, yr < 40 45 (18)
40–60 164 (63)
> 60 48 (19)
Cancer site Buccal mucosa 119 (46)
Tongue 63 (25)
Lower gingiva 33 (13)
Other sites 42 (16)
as T2, 30 (11.7%) as T3 and 66 (25.7%) as T4.
Pathology was classified as N0 in 202 (78.6%),
N1 in 23 (8.9%), and N2 in 32 (12.5%) (Table 2).
The 257 cases with SOHND included 162 (63%)
clinical N0 cases and 95 (37%) clinical N+ cases
(Figure 1). Among the 162 clinical N0 cases, 15
(9.3%) were clinically false negative cases (N1 = 9,
N2 = 6), of which three (N1 = 1, N2 = 2) had 
recurrent neck cancer in the dissected neck with 
a neck failure rate of 20% (3/15). One (N2) of
the three neck recurrence cases was found outside
of the operative field of the SOHND. Among the
162 clinical N0 cases, 147 (90.7%) were true nega-
tive cases, of which nine had recurrent neck cancer
in the dissected neck with a neck failure rate of
6.1% (9/147). All of the recurrences were within
the area of the prior SOHND site. Among the
95 clinical N+ cases, 55 (57.9%) were clinically
false positive, of which 12 had recurrent neck can-
cer with a neck failure rate of 21.8% (12/55). All
of the recurrences were within the area of the
prior SOHND site. Among the 95 N+ cases, 40
(42.1%) were clinically true positive cases (N1 =
14, N2 = 26), of which 16 (N1 = 4, N2 = 12) had
recurrent neck cancer resulting in a neck failure
rate of 40% (16/40) (Figure 1). Four of the 16
neck recurrences occurred outside the operative
field of the SOHND and all were pathologic N2,
with three in level IV and one in level V.
tPostoperative radiotherapy totaling at leas
5000 cGy was given to the neck sites of 62 pa-
tients, including 56 with pathologic N+ xand si
with perineural invasion, close surgical margin,
or advanced primary tumor (T3 and T4). Three
patients discontinued radiation therapy because
of intolerance.
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Table 2. Pathologic T and N status of 257 patients with oral squamous cell carcinoma
T status
T1 T2 T3 T4
Total, n (%)
N status
N0 51 75 24 52 202 (78.6)
N1 7 9 3 4 23 (8.9)
N2 6 13 3 10 32 (12.5)
Total, n (%) 64 (24.9) 97 (37.7) 30 (11.7) 66 (25.7) 257
Neck failure (9/147)
Clinical N0
162 (63%)
Neck failure (12/55)
Pathologic N– (57.9%)
55
Pathologic N– (90.7%)
147
Pathologic N+ (42.1%)
N1=14
N2=26
Pathologic N+ (9.3%)
N1=9
N2=6
Neck failure (3/15)
N1=1
N2=2
Neck failure (16/40)
N1=4
N2=12
Clinical N+
95 (37%)
257 cases with SOHND 
iF gure 1. f h l l f h d h d k d ( )Summary o  t e c inica  outcome o  257 patients w o un erwent supraomo yoi  nec  issection SOHND .
The 257 patients were divided into four groups based on pathologic findings. The clinically false negative group (n = 15)
had occult positive lymph nodes and a neck failure rate of 20% (3/15). The clinically true negative group (n = 147) and
clinically false positive group (n = k55) included patients whose lymph nodes were negative histologically and had nec
failure rates of 6.1% (9/147) and 21.8% (12/55), respectively. The clinically true positive group (n = f40) consisted o  
patients whose SOHND had a neck failure rate of 40% (16/40).
The 3- and 5-year overall neck disease-free
survival rates were 79.8% and 77.6%, respectively
(Figure 2). The 3- and 5-year neck disease-free
survival rates were 86.7% and 84.2% for patho-
logic N0 cases, 56.9% and 56.9% for pathologic
N1 cases, and 27.5% and 27.5% for pathologic
N2 cases (Figure 3, Table 3). Log rank test showed
significant differences in overall disease-free
survival rates of p= 0.064 for pathologic N0 vs. N1
cases, <0.0001 for pathologic N0 vs. N2 cases, and
0.008 for pathologic N1 vs. N2 cases (Figure 3).
Discussion
The comprehensive removal of cervical lymph
nodes, spinal accessory nerve, internal jugular vein,
and the sternocleidomastoid muscle using radical
neck dissection (RND) was systematically described
by Crile in 1906.15  This operative procedure
ghas significant long-term morbidity, includin
shoulder dysfunction, cosmetic deformity, cuta-
rneous paresthesia and chronic neck and shoulde
pain syndrome. These morbidities are exacerbated
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overall neck disease-free survival rates of 79.8%
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when postoperative radiotherapy is added. Owing
to the significant functional and esthetic mor-
bidity associated with RND, Suarez16 first intro-
duced functional neck dissection (FND) in the
early 1960s. FND preserved the spinal accessory
nerve, internal jugular vein and the sternocleido-
mastoid muscle, resulting in less morbidity than
RND, and the technique was designated as mod-
ified radical neck dissection (MRND) by American
head and neck surgeons.4 In the 1970s, studies
revealed that lymphatic groups at risk for a par-
ticular primary site are predictable.17 SND, intro-
duced in the 1980s, removes a selected group of
lymph nodes with high risk occult metastasis.
The rationale for elective SOHND for OSCC is
influenced by the pattern of spread of cancer to
the neck, as described by Lindberg.18 It is well
documented that if the levels I–III lymph nodes
with the highest risk of metastasis are shown to
have no metastasis after removal by SOHND, the
likelihood of level IV or V lymph node metastasis
is extremely low.
The factors influencing neck disease-free
survival rates after SOHND include incomplete
SOHND, histopathology and radiotherapy.13 The
histopathologic factor is micrometastasis beyond
the pathologic slicing detected nodes.19 Previously
reported neck failure in histopathologic N0 necks
is therefore likely to be related to the varying dili-
gence of the pathologist in the assessment of the
operative specimen. The radiotherapeutic factor
is discontinuation of radiotherapy. In the present
study, the neck failure rate was 20% for clinically
false negative cases, 6.1% for clinically true nega-
tive cases, 21.8% for clinically false positive cases,
and 40% for clinically true positive cases. In 1972,
Fletcher 20 reported that 5000 rads by radiotherapy
was sufficient to control subclinical disease in
the neck. The neck failure rates of clinically false
ynegative and true positive groups in this stud
were obviously higher than those of other stud-
ies.9,21 Moreover, the high neck failure rates in
rthis study might be attributable to rejection o
intolerance of radiotherapy in some cases result-
ing in discontinuation of radiotherapy. Increases
in the overall neck failure rate were also observed.
However, the neck failure rates for clinically true
ynegative and false positive groups in this stud
were similar to those of other studies.9,21 There-
rfore, SOHND may be an accurate procedure fo
selective OSCC cases.
cDespite the effective staging and therapeuti
procedure for clinical N0 cases,8,21 fthe use o
SOHND as a therapeutic procedure for clinical
N+ rcases remains very controversial. RND o
MRND are commonly used surgical procedures
for the treatment of the N+ neck. However, the
trend toward minimizing tissue loss from an ex-
tirpative procedure with preservation of function
fhas resulted in an increasing interest in the use o
various modifications of RND. When using a
more selective surgical procedure in selected N+
patients, regional control achieved a comparable
result to that of MRND.8,22,23 Kolli et al3 reported
ythat SOHND in patients with pathologicall
r positive nodes in the neck was inadequate fo
regional control without postoperative radiation
therapy. In the absence of factors that violate the
fascial compartments of the neck or disrupt lym-
phatic flow, such as massive adenopathy or gross
extracapsular spread, the rationale behind this
procedure remains viable.22 Medina and Byers8
suggested that SOHND is primarily indicated
for patients with T2, T3, and T4N0, and selected
N1 OSCC. Spiro et al9 creported that therapeuti
SOHND in conjunction with postoperative ra-
gdiation therapy is highly effective in controllin
N1, N2a and N2b. Jeroen et al23 tfound tha
kSOHND is inadequate for clinically positive nec
disease due to the higher risk of metastases in
rlevel IV; therefore, MRND was recommended fo
rsuch cases. In the present study, the 3- and 5-yea
neck disease-free survival rates were 86.7% and
Supraomohyoid neck dissection
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Table 3. The 3- and 5-year neck disease-free
survival rates according to pathologic 
N status*
3 years 5 years
N0 86.7% (2.7%) 84.2% (3.1%)
N1 56.9% (18.3%) 56.9% (18.3%)
N2 27.5% (13.3%) 27.5% (13.3%)
*Data presented as cumulative survival (standard error).
84.2% for N0 cases, 56.9% and 56.9% for N1
cases, and 27.5% and 27.5% for N2 cases. No
neck recurrence was found between 3 and 5 years
in N1 and N2 cases in this study, resulting in
identical 3- and 5-year neck disease-free survival
rates. The results of this study indicate that
SOHND is therapeutic for patients with patho-
logically uninvolved neck. The lack of significant
difference in the 3- and 5-year neck disease-free
survival rates between N0 and N1 cases suggests
that SOHND may be utilized in OSCC patients
with clinical N0 and N1 necks. Johnson et al24
found that if multiple positive nodes and/or 
extracapsular extension were present, most recur-
rences were in the dissected field. Thus, when
SOHND is used for OSCC patients with clinical
N2 neck, combined radiotherapy or RND is in-
deed needed.
The predictive value of neck node involve-
ment on recurrence and survival in OSCC is well
known, but whether this predictive value on sur-
vival holds in patients with occult metastases or
micrometastases is unclear.2 Whether early treat-
ment of occult neck disease results in better sur-
vival remains controversial. By contrast, the type
of therapeutic approach used to control regional
lymphatic spread in the neck plays an essential
role in prognosis. For the clinical N0 neck, a wait-
and-see approach or immediate elective SOHND
is indicated. Fakih et al25 found no significant
difference in survival rate between the two strate-
gies. On the other hand, Kligerman et al26 reported
a significantly decreased regional recurrence rate
and improved 3-year survival with elective SOHND
in a series of 67 patients with T1N0 and T2N0
oral cancers. In the present study, SOHND was
our general protocol for the clinical N0 neck,
except for patients with old age or medical com-
promise, who were treated using the wait-and-
see strategy.
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